Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Will Keep Its Positive Trend Going?

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Will Keep Its Positive Trend Going?

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Will Keep Its Positive Trend Going?

Can Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Continue Its Bullish Trend?

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has seen its share price leap +10.32% higher in the last 30-day period, but can it continue this positive trend? In calendar 2017 alone, the company’s stock has tumbled +16.81% higher. In the past 12 months, Rigel Pharmaceuticals, Inc. has risen +15.83%. The stock’s 52-week range is $1.94 to $ 4.38, and its three-month range has been $2.27 to $3.48.

At the moment, the company has 128.32M shares outstanding – bringing its market capitalization to $356.73M.

The stock’s 5-day moving average is currently $2.60, which is -6.47% below its most recent closing price of $2.78. The company’s 50-day moving average is $2.70, or -2.88% below the stock’s latest closing price, and its 100-day moving average is $2.68 – just -3.6% below its most recent closing price.

What is Wall Street saying?

The company’s stock is currently holding an average analyst rating of Strong Buy, according to the ratings of 4 Wall Street analysts. Of that group, no analysts rated Rigel Pharmaceuticals, Inc. as a Moderate Buy, 0 analysts rated it as a Hold, and no analysts rated it as a Strong Sell.

The company’s average rating has changed in recent months. Three months ago, 5 analysts weighed in on the stock – with 5 analysts rating it as a Strong Buy, no analyst rating it as a Moderate Buy, 0 analysts giving it a Hold, and no final analyst giving it a Strong Sell.

Diving Into Rigel Pharmaceuticals, Inc.’s Financials

Checking out a company’s Return on Assets (ROA) is useful in that it allows us to assess how well it is turning a profit in relation to its total assets. At the moment, Rigel Pharmaceuticals, Inc.’s ROA is -73.00%. The larger a company’s ROA, the better it is at generating income using its available assets.

Looking at a company’s gross margin shows us how much of its total sales revenue is not used on the cost of goods sold (COGS). In other words, gross margin shows the percentage of revenue retained when we exclude how much was spent on producing the sold goods.

We can also check out Rigel Pharmaceuticals, Inc.’s profit margin to see how it has been performing recently. We get a company’s profit margin when we divide its net income by its net sales.

Rigel Pharmaceuticals, Inc.’s operating margin is unknown. A company’s operating margin gives us insight into its operating efficiency and pricing strategy, by removing both depreciation and operating costs from net sales.

Investing is speculative. When investing your capital is at risk. This site is not intended for use in jurisdictions in which the trading or investments described are prohibited and should only be used by such persons and in such ways as are legally permitted. Your investment may not qualify for investor protection in your country or state of residence, so please conduct your own due diligence. This website is free for you to use but we may receive commission from the companies we feature on this site. Click here for more information.